US Patent Issued to Chiesi Farmaceutici on July 15 for "Aerosol formulation for COPD" (Italian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,568, issued on July 15, was assigned to Chiesi Farmaceutici S.p.A. (Parma, Italy).

"Aerosol formulation for COPD" was invented by Sauro Bonelli (Parma, Italy), Francesca Usberti (Parma, Italy) and Enrico Zambelli (Parma, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "Stable aerosol solution formulations comprising glycopyrronium bromide are useful for administration to patients with COPD and other respiratory conditions."

The patent was filed on Jan. 11, 2023, under Application No. 18/153,096.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%...